IP Library Patent Application 12897084
Patent Application
App. No. 12/897,084

SYSTEMS AND METHODS FOR DEFINING A TRANSITION POINT OF A FOOT PEDAL OF AN OPHTHALMIC SURGERY SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/897,084
Filed
Oct 4, 2010
Art Unit
3769
USPC
606/1
Abstract

An ophthalmic surgery system includes an ophthalmic surgical console and a foot control assembly operably coupled to the ophthalmic surgical console and including a foot pedal depressible through a range of motion. The range of motion includes a first region for controlling a first function associated with a surgical handpiece operably coupled to the ophthalmic surgical console, a second region for controlling a second function associated with the surgical handpiece, and a transition point between the first region and the second region. The ophthalmic surgical console is configured to assign the transition point, in response to a setup routine, to an actual position of the foot pedal as defined by a user depressing the foot pedal.

Claims (20)

1 . An ophthalmic surgery system comprising:

an ophthalmic surgical console;

a foot control assembly operably coupled to the ophthalmic surgical console and including a foot pedal depressible through a range of motion;

the range of motion including a first region for controlling a first function associated with a surgical handpiece operably coupled to the ophthalmic surgical console, a second region for controlling a second function associated with the surgical handpiece, and a transition point between the first region and the second region; and

wherein the ophthalmic surgical console is configured to assign the transition point, in response to a setup routine, to an actual position of the foot pedal as defined by a user depressing the foot pedal.

2 . The ophthalmic surgery system of claim 1 , wherein the setup routine includes a mark command received by the ophthalmic surgical console to indicate the foot pedal is disposed at said actual position.

3 . The ophthalmic surgery system of claim 1 , wherein the ophthalmic surgical console includes an input device to receive a setup command from a user, the setup command initiating the setup routine.

4 . The ophthalmic surgery system of claim 1 , wherein the ophthalmic surgical console includes a memory, said setup routine being stored in memory and executable by the ophthalmic surgical console.

5 . The ophthalmic surgery system of claim 1 , wherein the range of motion includes a third region and a second transition point between the second region and the third region, the ophthalmic surgical console being configured to assign the second transition point, in response to said setup command, to a second actual position of the foot pedal within the range of motion as defined by a user depressing the foot pedal.

6 . The ophthalmic surgery system of claim 1 , wherein the range of motion includes at least one of a pitch range of motion and a yaw range of motion.

7 . The ophthalmic surgery system of claim 1 , wherein the ophthalmic surgical console is configured to automatically initiate the setup routine in response to a surgical handpiece and/or the foot control assembly being coupled to the ophthalmic surgical console.

8 . A method of defining a transition point between a first region and a second region of foot pedal of a foot control assembly operably coupled to an ophthalmic surgical console, the foot pedal movable in a range of motion including the first region and the second region, the method comprising:

initiating a setup routine; and

assigning the transition point between the first region and the second region to an actual position of the foot pedal as defined by a user depressing the foot pedal.

9 . The method of claim 8 , further comprising receiving a mark command to an input device of the ophthalmic surgical console, indicating the foot pedal is disposed in said actual position.

10 . The method of claim 8 , wherein the range of motion includes a pitch range of motion and a yaw range of motion.

11 . The method of claim 8 , furthering comprising receiving a signal indicative of the actual position of the foot pedal within the range of motion.

12 . The method of claim 8 , wherein initiating the setup routine includes receiving a setup command from a user.

13 . The method of claim 8 , further comprising assigning a second transition point between the second region and a third region to a second actual position of the foot pedal as defined by a user depressing the foot pedal.

14 . An ophthalmic surgery system comprising an ophthalmic surgical console having a memory, a foot control assembly operatively coupled to the ophthalmic surgical console, the foot control assembly having a foot pedal movable through a range of motion, and a program stored in the memory and executable by the ophthalmic surgical console for initiating a setup routine and assigning a transition point between a first region and a second region, in response to a setup routine, to an actual position of the foot pedal as defined by a user depressing the foot pedal.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2010
From: ANDERSOHN, LUTZ
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 025092/0957 →